Margareth C. Ozelo
Campinas, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Global Multicenter Study Establishing the Reference Range for ISTH-BAT Bleeding Scores in Individuals Under 18 Years: Communication from the SSC of the ISTH.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 18, 2026
Safety of Damoctocog Alfa Pegol in Patients With Severe Haemophilia A Aged 7 to <12 Years of Age: Pooled Data From PROTECT VIII Kids and Alfa-PROTECT.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 18, 2026
Prospective collection of bleeding rate and factor usage in participants with hemophilia A and B in a noninvestigational product study.
Journal: Research and practice in thrombosis and haemostasis
Published: March 13, 2026
Plain Language Summary on Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.
Journal: European journal of haematology
Published: November 28, 2025
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results.
Journal: Research and practice in thrombosis and haemostasis
Published: October 02, 2025
Long-term durability of rAAV gene therapy in hemophilia: Factor expression, clinical outcomes and underlying molecular mechanisms.
Journal: Blood reviews
Published: August 17, 2025
Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.
Journal: European journal of haematology
Published: July 18, 2025
Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 13, 2025
Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice.
Journal: Research and practice in thrombosis and haemostasis
Published: March 04, 2025
New insights into Wiskott-Aldrich syndrome: ten novel WAS mutations and their clinical impact in a Brazilian cohort.
Journal: Frontiers in immunology
Published: February 28, 2025
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 05, 2025
Last Updated: 09/26/2026